Patrick Donnelly

Board Member

Mr. Donnelly, who has more than 35 years of experience, was most recently Chairman and Chief Executive Officer of Aptiv Solutions, a global pharmaceutical development services business he founded which sold to ICON (NASDAQ:ICLR) in May 2014. Prior to this, Pat served as President, Chief Executive Officer, and was one of the founders of PRA International (now PRA Health Sciences, NASDAQ:PRAH). He was instrumental in building PRA over twelve years from a small regional contract research organization to a global leader in the industry. Mr. Donnelly received his M.B.A. from Pennsylvania State University in 1984 and received his BS from the University of Missouri in 1980.

Pat currently serves as a board director for Linden portfolio companies, ProPharma Group, and Advarra.  Pat is also a board director at MedGenesis Therapeutix, Phase 5 LLC, and Rediscovery Life Sciences.

Company Blog

April 11, 2019
Utilizing an Agile Framework When Implementing ATMPs
Agile methodology presents a solution for organizations needing to address the timeline constraints of… Read More
April 4, 2019
Meet the Expert: Mary Speckin
Get to know Mary Speckin, Senior Medical Information Specialist at ProPharma Group Read More
March 15, 2019
Assumed Brexit & Batch Control Testing Site In UK
Understanding the European Commission (EC) notice on the European rules for batch control testing… Read More
More Articles

UPCOMING Events

May 15, 2019
ISPE Midwest Tech Ed Day
Join us at Arrowhead Stadium for the ISPE Midwest Chapter’s Annual Tech Ed Day! Make plans to attend, an... Read More
September 09, 2019
Cell & Gene Therapy Conference
Meet ProPharma Group at the Cell and Gene Therapy Conference for Bioprocessing and Commercialization, part of ... Read More
November 11, 2019
Biomanufacturing World Summit
The Biomanufacturing World Summit brings together the “who’s who” of pharmaceutical executives and cutti... Read More
All Events
Contact Us